Retrospective analysis of bevacizumab-induced arthralgia and clinical outcomes in ovarian cancer patients. Single center experience

• Κύριοι συγγραφείς: Maria Kaparelou (Συγγραφέας), Michalis Liontos (Συγγραφέας), Pelagia Katsimbri (Συγγραφέας), Aggeliki Andrikopoulou (Συγγραφέας), Alikistis Papatheodoridi (Συγγραφέας), Anastasios Kyriazoglou (Συγγραφέας), Aristotelis Bamias (Συγγραφέας), Flora Zagouri (Συγγραφέας), Meletios Athanasios Dimopoulos (Συγγραφέας)
• Μορφή: Βιβλίο
• Έκδοση: Elsevier, 2022-04-01T00:00:00Z.
• Θέματα: article
• Διαθέσιμο Online: Connect to this object online.

Background: Joint manifestations are ill-defined adverse events that were frequently reported of bevacizumab in ovarian cancer patients. The aim of this study is to describe the incidence and severity of joint manifestations among bevacizumab treated patients as well as their relation to clinical ou...